Long-acting Reversible Contraceptive (LARC)

Showing 9-16 of 43 results

Research roundup: July 2024 edition

Doctor-messengers are valuable communicators about abortion, impact of the shot on medication abortion efficacy, common misconceptions about IUDs, and precoital EC.

Research roundup: May 2024 edition

Patient characteristics of IUD placement under sedation, two studies on EC efficacy, substance use and anxiety among patients seeking an abortion, and genital herpes prevalence.

Research roundup: March 2024 edition

OTC birth control pill self-selection, adherence, and interest; IUD expulsion risks; and IUD and implant side effects.

Research roundup: January 2024 edition

Young people’s concerns about birth control and fertility, expanding EPT and PrEP in the ED, spike in EC demand around the New Year, and abortion decision making.

Research roundup: September 2023 edition

Patients' preferences for contraceptive educational materials, management of missing IUD strings and migrated IUDs, and providers’ perspectives on how to improve contraceptive counseling.

Research roundup: August 2023 edition

COX-2 inhibitor demonstrates potential in increasing efficacy of OTC LNG-EC pills; updated systematic review and meta-analysis supporting the effectiveness and safety of misoprostol-alone for medication abortion; support needs of adolescents and young adult abortion seekers; and more!

Research roundup: June 2023 edition

Men’s willingness to use novel birth control, characteristics of patients seeking telehealth medication abortion care, mifepristone as a potential treatment for adenomyosis, and the impact of the pill on adolescent bone health.

Research roundup: December 2022 edition

#IUD on TikTok, factors associated with pain during medication abortion, continuation rates of IUDs placed as EC at one year, and racial differences in birth control method provision for adolescents.
  • Previous
  • 1
  • 2(current)
  • 3
  • 4
  • 5
  • Next